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Abstract: A critical step in the supply of substrate for the phos-
phoinositide signal transduction pathway is the formation of the
liponucleotide intermediate, CDP-diacylglycerol, catalyzed by
CDP-diacylglycerol synthase. Further insight into the regulation
of phosphoinositide biosynthesis was sought by cloning of the
gene for the vertebrate enzyme. Sequence ofthe corresponding
gene from Drosophila was used to prepare a probe for screening
of a human neuronal cell cDNA library. A cDNA was isolated
with a predicted open reading frame of 1,332 bases, encoding
a protein of 51 kDa. The amino acid sequence showed 50%
identity (75% similarity) to that of Drosophila eye COP-diacyl-
glycerol synthase and substantial similarity to the Saccharo-
myces cerevisiae and Escherichia co/i homologues. Northern blot
analysis, with human cDNA riboprobes, suggested that the cor-
responding mRNA was expressed in all human tissues exam-
ined. Expression of the human cDNA in COS cells resulted in
a more than fourfold increase in CDP-diacylglycerol synthase
activity. Knowledge of the sequence of vertebrate CDP-diacyl-
glycerol synthase should facilitate further investigations into its
regulation and the possible existence of distinct isoforms. Key
Words: Phosphoinositides—Inositol lipids—Signal transduc-
tion.
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The phosphoinositide signal transduction pathway plays
a major role in cell—cell communication within the CNS
(Fisher et a!., 1992). Although many aspects of this second
messenger system have been investigated in great detail,
comparatively little is known regarding the regulation of the
availability of its phospholipid substrate, phosphatidylinosi-
tol (P1) 4,5-bisphosphate (PIP2). Prolonged stimulation of
phospholipase C may result in depletion not only of PIP2,
but also of P1. The continued operation of this pathway
would require resynthesis of P1 from its liponucleotide pre-
cursor, CDP-diacylglycerol (CDP-DAG) (Agranoff et a!.,
1958). The very low tissue levelsof the CDP-DAG (Thomp-
son and MacDonald, 1976) suggest that the reaction cata-
lyzed by its biosynthetic enzyme, CDP-DAG synthase
(CDS), may be rate-limiting for phosphoinositide synthesis
and thus may be apotential site ofregulation. Such a regula-
tory role is supported by the finding that mutations in a
photoreceptor-specific isoform of CDS in Drosophila re-
sulted in light-dependent retinal degeneration (Wu et al.,
1995). Conversely, overexpression of eye CDS gave rise to
an amplification of the light response. The results of the
Drosophila study also indicate that discrete CDS isoforms
may subserve specific cellular functions, for example, signal
transduction versus other metabolic needs of the cell. In
eukaryotic cells, CDP-DAG is a precursor not only of the
phosphoinositides but also of the mitochondrial phosphati-
dylglycerols, including cardiolipin. A dual localization of
CDS in both mitochondrial and microsomal fractions has
been documented (Kent, 1995), and evidence indicating the
existence of distinct isoforms of CDS in these compartments
has been reported (Mok et al., 1992).
The cDNAs encoding the enzyme have been cloned from
Escherichia coli (Ichoet al., 1985) andSaccharomyces cere-
visiae (Shen et al., 1996), in addition to Drosophila (Wu
et al., 1995). Further progress in understanding the role
playedby CDS in regulation of neuronal signal transduction
requires the cloning and characterization of a vertebrate
CDS. Here we describe the cloning, sequencing, andexpres-
sion of aeDNA encoding a human neuronal CDS. A prelimi-
nary report of this study has appeared in abstract form (Hea-
cock et al., 1996).
MATERIALS AND METHODS
Cloning and sequencing
A fragment corresponding to nucleotide residues 66—172
of a 1 94-bp human pancreas cDNA sequence (GeriBank
accession no. Tl 1364) was amplified by PCR from human
pancreas eDNA (Clontech) and then subcloned into pGEM-
T (Promega) and sequenced. The cDNA fragment was then
labeled with [a-
32P I dATP by random priming and u ed to
scr en ahuman NT2 (uninduced) neuronal cell library (ZAP
Express; Stratagene). Screening of 9 X i0~phages yielded
five positive clones (cds 1—5), four of 2.3 kb and one of 2.1
kb, which were plaque-purified using standard techniques.
Following in vivo excision of the pBK-cytomegalovirus
(CMV) phagemids, nucleotide sequencing of the inserts was
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performed by the dideoxy chain termination method with
either Sequenase or Taq DNA polymerase (Amersham) and
targeted oligonucleotide primers. Sequence analysis was ac-
complished using the University of Wisconsin Genetics
Computer Group software package.
Transfection of COS cells
COS cells were transiently transfected by acalcium phos-
phate precipitation method with a modified version of the
cds-5 pBK-CMV plasmid. Because the 5 ‘-untranslated re-
gion of cds-5 contained a stop codon, this regionwas deleted
together with the vector sequence downstream of the NheI
site adjacent to the CMV promoter, up to and including the
EcoRI multiple cloning site. A Kozak sequence (Kozak,
1991) was created at the ATG initiation codon, and a His6-
FIG. 1. Comparison of amino acid sequenceof human
NT2 cell CDSwith Drosophila, Saccharomyces cerevi-
siae (yeast), and Escherichia coil sequences. Identical
residues are shaded in gray. Numbers on the left refer
to positions in the human sequence. Alignments were
carried out using the Gap program.
tag sequence was inserted immediately 3’, to increase effi-
ciency of translation and allow purification by Ni
2~affinity
hromatog phy, respective y. Control COS cells were trans-
fected with the unmodified cds-5 plasmid, which in prelimi-
nary experiments was found not to result in any change in
CDS activity. Transfection efficiency, determined by co-
transfection with a ~3-galactosidase-CMV vector, averaged
20—30%.
Assay of CDS
Transfected cells were harvested after 48 h and then soni-
cated in 50 mM Tris-maleate buffer (pH 6.5), containing 1
mM phenylmethylsulfonyl fluoride. Assay tubes contained
1 mM phosphatidic acid (egg; Sigma), 1 mM [a-32P]CTP
(2.2>< lO~dpmlnmol), 1 mg/ml bovine serum albumin, 10
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mg/ml azolectin (soybean phosphatidyicholine; Sigma), 20
mM MgC12, and 30—40 ~.igof cellular protein in a final
volume of 200 ~l (modified from the procedure of Sparrow
andRaetz, 1985; Kelleyand Carman, 1987). Reactions were
stopped after 6 or 8 mm by addition of 1.7 ml chloroform!
methanol (1:2 vol/vol), lipids were acid-extracted (Fisher
and Agranoff, 1980), and radioactivity in 1.0-ml aliquots of
the organic phase was determined. Data are expressed as
mean ±SEM values. Statistical significance was assessed
by Student’s t test.
Protein concentration was determined by the method of
Bradford (1976).
Northern analysis
A human multi-tissue northern blot, containing ~-~2~sgof
poly (A) + RNA per lane, was purchased from Clontech. For
riboprobe synthesis, either a 725-bp PstI— BamHI restriction
fragment (containing 553 bases of the C-terminal coding
region) or a 360-bp EcoRI— PstI restriction fragment of cds-
5 was inserted into a pGEM-T vector (Promega). The re-
sulting plasmid was digested with Hindlil or EcoRI, respec-
tively, followedby labelingwith [a-
32P I UTP in thepresence
of T7 RNA polymeras . Blots were hybridized overnight at
60°Cin a solution containing 400 mM sodium phosphate
buffer (pH 7.2), 1 mM EDTA, 5% sodium dodecyl sulfate
(SDS), 1 mg/ml bovine serum albumin, and 50% for-
mamide, then washed in 15 mM NaC1, 1.5 mM sodium
citrate, and 0.1% SDS at 65°C,andexposed to Kodak XAR-
5 film.
RESULTS AND DISCUSSION
Comparison of the sequence of Drosophila CDS with the
data base of expressed sequence tags revealed a matching
partial eDNA sequence from human pancreas. This fragment
was amplified by PCR and used to screen a human NT2
neuronal cell eDNA library. Of the five positive clones iso-
lated, the four 2.3-kb clones had identical restriction digest
patterns. Partial sequencing of the 2.1-kb clone indicated
that it was closely related to the larger clones and that two
deletions, one of 111 bp in the 5 ‘-untranslated region and
one of 117 bp in the C-terminal coding region, accounted
for the smaller size. The latter deletion did not disrupt the
reading frame, but it remains to be determined if the 2.1-kb
clone encodesa functional protein. One ofthe 2.3-kb clones,
cds-5, was completely sequenced on both strands. It con-
tained a predicted open reading frame of 1,332 bases, pre-
ceded by stop codons in all three reading frames, encoding
aprotein of 444 amino acids with amolecular mass of 51,486
Da. The 3 ‘-untranslated region did not contain a potential
polyadenylation signal, indicating that although it contains
the entire coding region, cds-5 is a partial eDNA, probably
derived from thebinding of the oligo(dT) primer to an inter-
nal A-rich region rather than to thepoly (A) tail. The amino
acid sequence of the presumptive human enzyme is highly
homologous to Drosophila CDS (50% identity, 75% similar-
ity) and shares 37 and 31% identity with the S. cerevisiae
and E. coli homologues, respectively (Fig. 1). Greater ho-
mologies were observed in regions that were highly con-
served, particularly in the C-terminal sequence.
Hydrophobicity analysis of the human enzyme (Kyte and
Doolittle, 1982) indicatedthree putativemembrane spanning
domains, consistent with the membrane localization of the
protein. All three eukaryotic enzymes contain a hydrophilic
N-terminal region that is lacking in the E. coli enzyme. The
FIG. 2. The tissue distribution ofCDS
mRNA in human tissues was analyzed
by northern blotting as described in
Materials and Methods. The 725-bp
Pstl—BamHl probe was used. Posi-
tions of RNA molecular weight mark-
ers are indicated.
latter is only one-half the size of its eukaryotic homologues,
suggesting that the N-terminal and C-terminal extensions
foundin the eukaryoticenzymes are not required for catalytic
activity and may subserve other functions such as organelle
targeting or regulation. No potential mitochondrial or endo-
plasmic reticulum targeting sequences were found in the
human eDNA. Of note are cysteine residues conserved
among the eukaryotic enzymes, at positions 306, 321, and
402 of the human sequence, with the latter two also shared
by the E. coli enzyme. The activity of the yeast enzyme is
reported to be sensitive to sulfhydryl inhibitors (Kelley and
Carman, 1987), as was the human enzyme. Treatment of
sonicated human neuroblastoma cells (SH-SY5Y) with 5
mM N-ethylmaleimide or 100 pM p -chloromereuriphenyl-
sulfonic acid resulted in 86 and 96% inhibition of CDS
activity, respectively. In contrast, N-ethylmaleimide did not
inhibit the E. coli CDS (Langley and Kennedy, 1978).
Confirmation of the protein encoded by cds-5 as CDS
was provided by expression in COS cells. This required
modification of the cds-5 pBK-CMV plasmid for removal
of a stop codon in the 5 ‘-untranslated region. CDS activity
in COS cells transiently transfeeted with the modified cds-
5 plasmid showed a mean increase of 4.3-fold (range, 2.8—
4.8-fold) over control COS cells (control vs. transfected,
0.17 ±0.04 vs. 0.73 ±0.10 nmol/min/mg of protein; n = 7;
p < 0.001). Attempts at Ni2~affinity purification of the
His
6-tagged protein have thus far been unsuccessful owing
to the inability to retain activity of the detergent-solubilized
enzyme. The distribution and size of CDS mRNA in human
tissues were determined by northern analysis (Fig. 2). A
band of ~-~5kb was present in all human tissues examined
and was particularly prominent in heart and liver. An addi-
tional band of 3 kb was present in heart and pancreas. At this
point it is unclear whether the two mRNAs may represent
alternatively spliced forms. Reprobing with an upstream
360-bp fragment gave the same pattern (data not shown).
The cds-5 eDNA thus appears to encode a ubiquitously
expressed protein that expresses CDS activity. The possibil-
ity of the existence of multiple isoforms of the enzyme re-
mains to be explored. Distinctly different properties have
been described for mitochondrial and microsomal CDS of
rat liver, supporting the hypothesis that these may represent
two distinct gene products. In the yeast, the CDS 1 gene was
found to encode >90% of CDS activity, and null mutants
were nonviable (Shen et al., 1996). In theDrosophila study,
preliminary results suggested the presence of alternatively
spliced CDS isoforms (Wu et al., 1995). The fact that Dro-
sophila CDS mutants are viable and show no defect other
than in photoreceptors points to the existence of other CDS
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isoforms for the supply of phosphoinositide precursor in
those mutants. The Drosophila eye CDS appears to be spe-
cialized for the phototransduction process, and the conse-
quences of alterations in its expression identify it as a key
enzyme in the phospholipase C signaling pathway. Given
the multitude of phosphoinositide-linked receptors in neural
tissue andthe importance of this pathway in neuronal signal-
ing, it is tempting to speculate that such a central role may
pertain also to neuronal CDS. The cloning of a vertebrate
CDS will facilitate understanding of its regulation, which
may, in addition, have implications for the growth factor-
linked P1-3-kinase pathway (Kapeller and Cantley, 1994),
for P1-anchored proteins (Low and Saltiel, 1988), cytoskele-
tal modulation (Janmey, 1994), and membrane trafficking
(De Camilli et al., 1996).
Note added in proof:The sequence reported in this article
has been deposited in the GenBank database (accession no.
U65887).
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